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Abstract
Background: The extended knee lateral midpatellar portal for intraarticular injection of the knee is accurate but is
not practical for all patients. We hypothesized that a modified anteriolateral portal where the synovial membrane
of the medial femoral condyle is the target would be highly accurate and effective for intraarticular injection of the
knee.
Methods: 83 subjects with non-effusive osteoarthritis of the knee were randomized to intraarticular injection using
the modified anteriolateral bent knee versus the standard lateral midpatellar portal. After hydrodissection of the
synovial membrane with lidocaine using a mechanical syringe (reciprocating procedure device), 80 mg of
triamcinolone acetonide were injected into the knee with a 2.0-in (5.1-cm) 21-gauge needle. Baseline pain,
procedural pain, and pain at outcome (2 weeks and 6 months) were determined with the 10 cm Visual Analogue
Pain Score (VAS). The accuracy of needle placement was determined by sonographic imaging.
Results: The lateral midpatellar and anteriolateral portals resulted in equivalent clinical outcomes including
procedural pain (VAS midpatellar: 4.6 ± 3.1 cm; anteriolateral: 4.8 ± 3.2 cm; p = 0.77), pain at outcome (VAS
midpatellar: 2.6 ± 2.8 cm; anteriolateral: 1.7 ± 2.3 cm; p = 0.11), responders (midpatellar: 45%; anteriolateral: 56%; p
= 0.33), duration of therapeutic effect (midpatellar: 3.9 ± 2.4 months; anteriolateral: 4.1 ± 2.2 months; p = 0.69), and
time to next procedure (midpatellar: 7.3 ± 3.3 months; anteriolateral: 7.7 ± 3.7 months; p = 0.71). The anteriolateral
portal was 97% accurate by real-time ultrasound imaging.
Conclusion: The modified anteriolateral bent knee portal is an effective, accurate, and equivalent alternative to the
standard lateral midpatellar portal for intraarticular injection of the knee.
Trial Registration: ClinicalTrials.gov: NCT00651625
Background
Intraarticular injection of the knee is the most common
invasive procedure in sports medicine, accounting for
approximately 39-64% of all outpatient joint procedures
[1-10]. A number of anatomic landmark palpation-
guided intraarticular injection approaches to the knee
are used including the extended leg lateral or medial
midpatellar approaches and the bent knee lateral and
medial anterior approaches [4,6,10-18]. While accessing
the anteriolateral and anteriomedial portals with the
patient in the sitting position with the knee bent, the
target is traditionally the synovial membrane reflections
in the intercondylar notch, but these approaches provide
only 71-75% accuracy [2,4,6,10-18]. Although the
extended leg lateral midpatellar approach has been
reported to be highly accurate (93%), there are certain
patients where the midpatellar approach may be imprac-
tical [2]. A knee injection technique that permits the
patient to remain in the sitting position with a bent
knee, but provides similar levels of accuracy and out-
come as the lateral midpatellar portal would be of clini-
cal utility [2,3,9].
We hypothesized that a modified anteriolateral portal
where the synovial membrane of the medial femoral
condyle is the needle target would be highly accurate
and provide equivalent clinical outcomes as the standard
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of the knee.
Methods
Subjects
This project was in compliance with the Helsinki
Declaration, approved by the institutional review board
(IRB), and is registered at ClinicalTrials.gov (Clinical
Trial Identifier NCT00651625). Inclusion criteria
included: 1) osteoarthritis oft h ek n e e ;2 )B r a n d tg r a d e s
1-3 osteoarthritis as diagnosed by radiographs, 2) persis-
tent pain in the involved joint, 3) significant pain in the
involved joint by 10 cm Visual Analogue Pain Sale (VAS)
where VAS ≥ 5 cm, 4) failure of exercise and oral analge-
sics, and 5) the recommendation from the physician for
an intraarticular injection [9,19] (6,50). Exclusion criteria
included 1) Brandt grade 4 osteoarthritis, 2) hemorrhagic
diathesis, 3) the use of warfarin or antiplatelet therapy, or
4) the presence of infection (6). A total of 83 knees with
osteoarthritis were randomized between the lateral mid-
patellar portal (40 knees) and the modified anteriolateral
portal (43 knees) (% difference: +8%; 95% CI: -8% to
+9%, p = 0.50). Subject age (midpatellar: 61 ± 10 yr; ante-
riolateral: 59 ± 14 yr; % difference: -3%; 95% CI: -12% to
+6%, p = 0.47), female gender (midpatellar: 80%; anteriolat-
eral: 88%; % difference: +13%; 95% CI: -10% to +31%; p =
0.47), subjects who completed study (100% for both, p =
0.5), and pre-procedure baseline pain (10 cm VAS; midpa-
tellar: 8.1 ± 2.0 cm; anteriolateral: 7.6 ± 2.2 cm; % differ-
ence: -6%; 95% CI: -18% to +5%; p = 0.28) were similar
between the two treatment groups. Outcomes included
procedural pain and injection pain, significant pain (VAS
≥ 5 cm), VAS pain scores at outcome (2 weeks and
6 months), mean change in VAS pain scores at outcome,
responders (asymptomatic joints at outcome defined by
VAS < 2 cm), non-responders (symptomatic joints at out-
come defined by VAS ≥ 2 cm), duration of therapeutic
effect (months), and time to reinjection or referral to sur-
gery (months). Cost-effectiveness was not calculated
because this is highly dependent on reimbursement that
varies widely from country to country [20].
Injection Technique
The one-needle two-syringe technique was used where
1) one needle is used for anesthesia, arthrocentesis,
hydrodissection, and intraarticular injection; 2) the first
syringe is used to anesthetize, aspirate effusion, and
hydrodissect and dilate the joint space, and 3) the sec-
ond syringe is used to inject the intraarticular therapy
[9]. For the modified anteriolateral portal, relevant ana-
tomic landmarks (patella, patellar tendon, lateral tibial
plateau, lateral femoral condyle, and medical femoral
condyle were palpated and marked with ink (Figure 1
and 2). The anteriolateral portal was defined by the
adjoining structures of inferiolateral border of the patel-
lar, the patellar tendon, and the lateral tibial plateau.
Rather than directing the needle to the traditional ante-
riolateral target, the intercondylar notch, the modified
anteriolateral approach targets the synovial membrane
of the medial femoral condyle (Figure 3) [2,9,21]. This
requires directing the needle from the anteriolateral por-
tal under the patellar tendon through the anterior fat
pad, until the needle tip directly penetrates the synovial
membrane and the bevel engages the medial femoral
condyle (Figure 3) [9]. The lateral midpatellar injection
was performed with the knee almost fully extended (in
10 to 15 degrees of flexion), and the needle was directed
from the lateral surface of the knee to the middle of the
patellofemoral joint (Figure 4) [2].
A 21 gauge 2.0 inch (5.1-cm) needle (305783-21 g BD
Needle, BD, 1 Becton Drive, Franklin Lakes, NJ 07417,
website: http://www.bd.com) was mounted on a 3 ml
mechanical syringe, the reciprocating procedure device
(RPD syringe) (AVANCA Medical Devices, Inc, Albu-
querque, New Mexico, USA. website: http://www.
AVANCAMedical.com). For very large individuals a 3.0
Figure 1 Palpation-Guided Anatomic Markers.A n a t o m i c
landmarks are first identified by palpation and marked with ink prior
to the procedure for both palpation-guided procedures. VL (vastus
lateralis), LF (lateral femoral condyle), LTP (lateral tibial plateau), PT
(patellar tendon), P (patella), T (target for anteriolateral bent knee
approach).
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RPD mechanical syringe is formed around the core of a
conventional syringe barrel and plunger, but has a paral-
lel injection plunger and an accessory barrel to control
the motion of the injection plunger (Figure 2, 3, and 4).
The two plungers are mechanically linked by a pulley in
an opposing fashion, resulting in a set of reciprocating
plungers. Thus, when the aspiration plunger is depressed
with thumb, the mechanical syringe aspirates, and when
the injection plunger is depressed with the thumb, the
syringe injects. This permits the index and middle fingers
to remain in one position during both aspiration and
injection, while the thumb only needs to move in a hori-
zontal plane to the alternative plunger in order to change
the direction of aspiration or injection. Mechanical syr-
inges permit easy detection of small amounts of synovial
fluid that flash back into the barrel confirming true
intraarticular positioning [9,22-25]. Prior to the proce-
dure the mechanical syringe was filled with 1% lidocaine
(3 ml for the knee) (Xylocaine
® 1%, AstraZeneca Phar-
maceuticals LP, 1800 Concord Pike, P.O. Box 15437,
Wilmington, DE 19850-5437). While alternatively aspir-
ating and injection, the needle tip was directed from the
anteriolateral portal across the knee towards the medial
femoral condyle until the needle tip penetrated the syno-
vial membrane and the needle encountered firm resis-
tance to further advance (Figure 2 and 3).
After the needle was advanced to the surface of the
medial femoral condyle, the lidocaine was injected
intraarticularly to hydrodissect and lift the synovial
membrane over the needle bevel, and using one hand
to hold the mechanical syringe and the other hand the
needle hub, the mechanical syringe was rotated off the
intraarticular needle, and a 3 ml conventional syringe
prefilled with 80 mg triamcinolone acetonide suspen-
sion (Kenalog
® 40, Westwood-Squibb Pharmaceuticals,
Inc (Bristol-Myers Squibb), 345 Park Ave, New York,
NY 10154-0004, USA) was rotated onto the intraarti-
cular needle, and the treatment was injected. The nee-
dle was extracted, and firm pressure applied to the
puncture site.
Determination of Intraarticular Injection Accuracy
To determine the intraarticular injection accuracy of the
modified anteriolateral bent knee portal, 76 consecutive
Figure 2 Introduction of the Needle from the Anteriolateral
Portal. The reciprocating procedure device (RPD) control syringe is
used with two hands to carefully introduce the needle and
administer lidocaine. Depressing one plunger causes the RPD
control syringe to aspirate and depressing the other causes the
device to aspirate. If no fluid is obtained the needle is advanced to
the medium femoral condyle.
Figure 3 Modified Anteriolateral Portal.W i t ht h em o d i f i e d
anteriolateral portal and the knee in the bent position, the needle is
directed from the anteriolateral portal, under the patellar tendon, to
the synovial surfaces of the medial femoral condyle rather than the
intercondylar notch.
Figure 4 Lateral Midpatellar Portal. With the lateral midpatellar
portal and the knee is almost fully extended, the needle is directed
from the lateral midpatellar position into the patellofemoral joint
space.
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injected using the bent knee modified anteriolateral por-
tal, and needle positioning and fluid flow determined by
sonography. To determine accuracy of needle placement
with sonography, the observer placed the long axis of
the ultrasound transducer over the anteriomedial por-
tion of the knee, such that the transducer was parallel
to the needle shaft and thus the ultrasound beam vector
would best approximate 90 degrees to the long axis of
the needle, providing optimal reflected ultrasound signal
and excellent visualization of the needle (Figure 5 and
6) [9]. A portable ultrasound unit with a 10-5 MHz
38 mm broadband liner array transducer (Sonosite
M-Turbo, SonoSite, Inc. 21919 30th Drive SE, Bothell,
WA 98021) was used to sonographically determine the
location of the medial femoral condyle, the position of
the needle tip, intraarticular and extraarticular fluid
flow, and dilation of the intraarticular space.
Two positions of the needle tip were tested: 1) when
the needle palpably engaged the medial femoral condyle,
and 2) when the needle did not palpably engage the
medial fem femoral condyle. True intraarticular posi-
tioning was established by demonstrating the sono-
graphic characteristics of the needle tip: 1) anatomic
positioning of the needle tip at the interface of synovial
membrane and cartilage (Figure 3 and 6), 2) demonstra-
tion of the free flow of fluid from the needle tip into the
intraarticular space and not into the anterior fat pad
(Figure 7), and 3) demonstration of dilation of the
intraarticular space with the injected fluid [9,14,26-29]
(Figure 7). Extraarticular injection was determined by
observing 1) fluid movement into the anterior fat pad or
retroflow of fluid back along the needle shaft, 2)
increased echogenicity in the septa of the anterior fat
pad, and 3) lack of fluid movement into and dilation of
the intraarticular space [9].
Statistical Analysis
Data were entered into Excel (Version 5, Microsoft,
Seattle, WA), and analyzed in SAS (SAS/STAT Software,
Release 6.11, Cary, NC). Differences in measurement
data were determined with the student t-test; categorical
data were determined with Fisher’s Exact Test, while
differences between multiple parametric data sets were
determined with Fishers Least Significant Difference
Method.
Results
Table 1 demonstrates the similarities in short-term out-
come between the lateral midpatellar and modified ante-
riolateral portals for injecting the knee. As can be, seen
there were no differences in pre-procedure pain (p =
0.28), needle introduction pain (p = 0.77), significant
needle introduction pain (p = 0.74), injection pain (p =
0.92), or significant injection pain between the two por-
tals (p = 0.90). Table 2 demonstrates the intermediate
(2 week) and long-term outcome (6 months). As can be
Figure 5 Placement of Ultrasound Probe. After introduction of
the needle, the ultrasound probe is placed over the anteriomedial
portal so that the ultrasound beam is at right angles to the needle
shaft optimizing visualization of the location of the needle tip
engaged to the medial femoral condyle.
Figure 6 Sonographic Visualization of Needle Placement.T h e
needle is advanced until the needle tip palpably engages the
medial femoral condyle.
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0.11), reduction in pain from baseline (p = 0.13),
responder rate (p = 0.33), and non-responder rate (p =
0.33). There were also no differences in pain at 6 months
(p = 0.89), duration of therapeutic effect (p = 0.69), or
time to next procedure (p = 0.71).
Accuracy of intraarticular injection using the bent
knee modified anteriolateral portal was highly dependent
on needle tip positioning. When the needle tip was not
positioned to directly and pa l p a b l ye n g a g et h em e d i a l
femoral condyle, true intra-articular injection was only
observed in 22% (17/76) of the test injections with the
bulk of the injection being deposited in the anterior fat
pad. When the needle was positioned so that it palpably
engaged the medial femoral condyle, after hydrodissec-
tion with lidocaine, accurate intraarticular injection was
demonstrated in 97% (74/76) of knees, resulting in a
+332% (95% CI: +289% to +372%) increase in intraarti-
cular injection success, significantly better than when
the needle was not positioned to engage the condyle
( p<0 . 0 0 1 ) .A l t h o u g ht h e2i n c h( 5 . 1c m )n e e d l ew a s
used in the majority of subjects, the needle was hubbed
or nearly hubbed against the skin in larger individuals in
order to palpably engage the medial femoral condyle,
t h u s ,t h eu s eo ft h e3i n c h( 7 . 7c m )n e e d l eo rl o n g e r
provided more leeway in large or obese individuals.
Discussion
The non-effusive or “dry joint” typical of osteoarthritis
of the knee is particularly challenging to the sports med-
icine proceduralist, and selection of anatomic approach
is of critical importance to ensure accuracy [2,16,17,21].
Several methods have been proposed to increase the
accuracy of intraarticular placement of the needle in the
absence of an effusion. These include careful selection
of the anatomic portal, preinjection of air, saline or lido-
caine to hydrodissect and dilate the intraarticular space,
aspiration of droplets of synovial fluid or moisture into
the barrel of the syringe, minimal retraction of the
needle tip after palpable engagement of an articular
cartilage or bone surface, use of highly controlled
mechanical syringes, the one-needle two syringe techni-
que, ultrasound guidance, or fluoroscopic injection of
contrast material [2,4,6,9-18].
Jones et al demonstrated that only 66% of palpation-
guided knee injections were truly intraarticular, while
Bliddal demonstrated that the superiolateral approach
was 91% accurate [11,13]. In a study with 11 subjects in
each arm, Toda et al demonstrated a that the modified
Figure 7 Sonographic Visualization of Direct Intraarticular
Injection. After the needle tip is advanced until it palpably engages
the medial femoral condyle, lidocaine is injected showing fluid
movement into the intraarticular space and dilation of the
intraarticular space. Here intraarticular movement of fluid is
demonstrated by color Doppler at the needle tip with simultaneous
dilation of the intraarticular space.
Table 1 Short-Term Outcomes for Intraarticular Injection of the Knee
Lateral Midpatellar
Portal
Modified Anteriolateral
Portal
Number of Subjects 40 43 Percent
Difference
95% Confidence
Interval
P Value
Pre-Procedure Baseline Pain (VAS) 8.1 ± 2.0 cm 7.6 ± 2.2 cm -6% -18% to +5% 0.28
Needle Introduction Pain (VAS) 4.6 ± 3.1 cm 4.8 ± 3.2 cm +4% -26% to +34% 0.77
Significant Needle Introduction Pain
(VAS ≥ 5 cm)
48% (19/40) 44% (19/43) -6% -49% to +37% 0.74
Injection Pain (VAS) 2.8 ± 2.8 cm 2.9 ± 3.4 cm +4% -45% to +53% 0.92
Significant Injection Pain (VAS ≥ 5 cm) 23% (9/40) 21% (9/43) +2% -71% to +86% 0.90
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manipulative ankle traction at 30 degrees of knee flex-
ion) was 100% accurate, bent knee anteriomedial
approach was 55% accurate, and the anteriolateral
approach was 55% accurate [30]. Lopes et al reported
100% accuracy in knee injection rates, but these were in
patients with rheumatoid arthritis where the target - the
synovial mass (both tissue and effusions) - is much lar-
ger than in osteoarthritis [31]. In contrast, Cunnington
et al reported only 66.3% accuracy in inflammatory
arthritis with palpation-guided methods [32]. In a cada-
ver study Esenyel et al have demonstrated a 56% to 85%
intraarticular injection accuracy depending on anatomic
approach with the anteriolateral approach being the
most accurate and the medial midpatellar portal being
the least accurate [21]. Wind et al demonstrated that
the superiomedial and superiolateral injections into the
knee were the most accurate, while the lateral joint line
injection was the most inaccurate [33]. Jackson et al
demonstrated that lateral midpatellar approach was the
most accurate (93% accuracy) while the anteriomedial
and anteriolateral portals were less accurate (71% and
75%, respectively) [2]. The target for the anteriolateral
and anteriomedial portals is generally the intercondylar
notch, which contains the cruciate ligaments and asso-
ciated synovial membrane reflections [2,21].
For those apprehensive individuals who involuntarily
and forcefully contract the quadriceps muscles during a
procedure, the elderly, individuals with knee contrac-
tures, the obese, or wheelchair-bound individuals, the
lateral midpatellar approach can be difficult and/or
inconvenient in these individuals. In addition since less
subcutaneous fat is transversed by the needle in the lat-
eral midpatellar portal, local complications of injections
are more easily observed, including visible ecchymosis,
hematoma, and cutaneous atrophy or foreign body gran-
uloma formation at the puncture site caused by reflux of
corticosteroid or hyaluron back through the needle tract
[2,34-39]. Thus, refinement of a method of injecting the
knee that permits the patient to remain in the sitting
position with a bent knee and does not require forcing
the needle into the constrained anatomy of the patello-
femoral joint, but provides similar levels of accuracy as
the lateral midpatellar portal would be of clinical utility
in certain individuals [2,21].
Because of the associated cruciate ligaments and
reflections of the synovial membrane, the intercondylar
notch presents a narrow anatomic target where the
synovial space and the araeolar synovial tissue cannot be
easily distinguished while advancing the needle tip, mak-
ing true anatomic injection difficult, resulting in only a
71% to 75% accuracy rate [2]. We hypothesized that a
modified anteriolateral portal where the synovial mem-
brane overlying the medial femoral condyle is the needle
target (Figure 3) would be accurate and provide equiva-
lent clinical outcomes as the standard lateral midpatellar
approach (Figure 4). The modified anteriomedial bent
knee portal proved highly accurate (97% intraarticular
accuracy) when the needle tip could be felt engaging the
medial femoral condyle, which compares favorably with
the 93% accuracy with the lateral midpatellar approach
[2]. Moreover, the modified bent knee anteriolateral
portal provided equivalent clinical outcomes to the stan-
dard lateral midpatellar approach (Table 1 and 2).
There are limitations to this study. First, this study
employed the one-needle two-syringe technique where a
first syringe is used to anesthetize, aspirate, hydrodissect,
and dilate the joint space. This technique may improve
intraarticular accuracy and outcomes independent of
anatomic portal because this maneuver in fact hydrodis-
sects and lifts the synovial membrane over the needle
bevel increasing true intraarticular injection accuracy
[9]. Similarly, the one-needle two-syringe technique per-
mits aspiration of synovial fluid prior to injection further
confirming intraarticular injection accuracy, decompres-
sing the joint, and improving outcomes as opposed to
direct injection without aspiration that does not
[10,13,40,41].
Table 2 Intermediate-Term and Long-Term Outcomes of IntraarticularInjection of the Knee
Lateral Midpatellar
Portal
Modified Anteriolateral
Portal
Number of Subjects 40 43 Percent
Difference
95% Confidence
Interval
P
Value
Pain at Outcome (2 weeks) (VAS) 2.6 ± 2.8 cm 1.7 ± 2.3 cm -35% -78% to +9% 0.11
Reduction in Pain from Baseline (VAS) 4.4 ± 3.4 cm 5.5 ± 3.1 cm +25% -7% to +57% 0.13
Responders (VAS < 2 cm) 45% (18/40) 56% (24/43) +24 -23% to +68% 0.33
Non-Responders (VAS ≥ 2 cm) 55% (22/40) 44% (19/43) -20% -56% to +19% 0.33
Pain at Outcome (6 months) (VAS) 4.9 ± 3.1 cm 4.8 ± 3.2 cm -2% -30% to +26% 0.89
Duration of Therapeutic Effect 3.9 ± 2.4 months 4.1 ± 2.2 months +5% -21% to +31% 0.69
Time to Next Procedure (reinjection or
referral to surgery)
7.3 ± 3.3 months 7.7 ± 3.7 months +6% -16% to +27% 0.71
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sia and hydrodissection. Although the local anesthetic
bupivacaine has resulted in chondrolysis and malpractice
actions, short-term exposure to low levels of lidocaine as
used in this study have not been demonstrated to be
chondrotoxic in vivo; furthermore, cases of chondrolysis
with lidocaine have not been reported in large case ser-
ies [10,23,42-45]. Lidocaine and chlorhexidine have the
additional benefit in that they are potent bactericidal
agents and may contribute to the low incidence of joint
infections and lack of chondrolysis associated with
intraarticular injections [23,36,46-49].
Another aspect of the modified anteriolateral injection
technique is that a 2 to 3 inch (5.1 to 7.7 cm) needle
(depending on knee subcutaneous and skeletal dimen-
sions) is necessary for this technique to be predictably
accurate so that the needle tip can effectively access the
joint space and palpably engage the medial femoral con-
dyle. Since the 2 inch needle was hubbed or nearly
hubbed in many individuals in order to palpably engage
the medial femoral condyle, the use of the more com-
mon 1.5 inch (3.8 cm) needle would likely to substan-
tially reduce the accuracy rates because the needle is too
short to reach the synovial space overlying the medial
femoral condyle and would only be useful in smaller
individuals. Also the use of the mechanical syringe
rather than a conventional syringe may have contributed
to improved intraarticular accuracy independent of por-
tal as mechanical syringes have been shown to be better
controlled and more accurate than a conventional syr-
inge, and reduce procedural trauma, accentuate synovial
fluid detection and removal, and improve intraarticular
injection outcomes with injection of local anesthetics,
hyaluron, and corticosteroid [9,23-25,50-55].
Conclusions
In summary, the palpation-guided bent knee modified
anteriolateral portal for intraarticular injection of the
knee where the synovial space overlying the medial
femoral condyle is the needle target is a highly accurate
alternative method to the lateral midpatellar portal and
provides high levels of accuracy with minimal pain while
maintaining excellent injection outcomes.
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